Led · Series A · Mar 2017

RenalGuard Solutions markets the RenalGuard platform and develops medical technologies for the cardiac and vascular markets. The company has launched Reprieve Cardiovascular, led by CEO Jim Dillon, to advance Guided Diuretic Therapy for patients with acute decompensated heart failure (ADHF). Reprieve's Guided Diuretic Therapy is intended to enable precise and predictable management of fluid levels in fluid-overloaded heart failure patients and to increase diuretic efficiency. The therapy is described as having potential to speed decongestion while protecting core organ function, shorten hospital stays, reduce readmissions, and improve symptoms such as shortness of breath, ascites, and swelling. Financially, RenalGuard completed a $7M financing announced in September 2018. The round was led by Abiomed with participation from existing investors. RenalGuard Solutions develops the RenalGuard system, designed to protect patients from acute kidney injury (AKI) including contrast-induced AKI by measuring urine output and automatically infusing hydration fluid. The company reports investigator-sponsored studies in Europe that demonstrated RenalGuard’s effectiveness at preventing CI-AKI in at-risk patients. RenalGuard is CE-marked and is sold in Europe and certain countries worldwide via a network of distributors. RenalGuard Solutions is led by Chairman Ethan Benovitz and is conducting the CIN-RG pivotal study in the United States to support a planned Premarket Approval filing with the U.S. Food and Drug Administration. The company plans to use new funding to complete its ongoing pivotal trial by year-end to support U.S. marketing approval in 2018, extend marketing and sales activities in Europe and other regions, and expand R&D into additional clinical indications. The device and ongoing trial position the company for regulatory progress and broader commercial expansion where the technology is available.

Led · Series A · Aug 2016

Revelator offers a B2B platform for distributing, selling and licensing music online, allowing customers to upload tracks and push them to digital stores and services like Spotify and Apple Music. The product bundles marketing and analytics tools, which the company says give it a data advantage for tracking usage and payments. Revelator cites examples such as enabling Boston public radio station WBUR to track podcast plays and compensate musicians and labels. The company has a distribution partnership with Wix, powering Wix Music customers to promote and sell their music. Leadership sees opportunities for geographic expansion in Europe and Asia and plans to build a payments platform to deliver faster payments and advances, including mobile payments for emerging markets. Financially, Revelator announced a $2.5M Series A and had previously raised $3M, bringing known funding to $5.5M. Revelator provides a cloud-based platform that integrates sales, marketing, accounting and analytics into a single system to simplify workflows, automation and efficiency for independent artists and record labels. It offers a low-cost monthly Business-as-a-Service subscription and plans to generate additional revenue from bundled add-on features, transactional and marketplace commerce. Led by founder and CEO Bruno Guez and Ollie Buckwell, Global Head of Business Development, the company launched its beta in Israel serving over 800 Israeli artists. Through a strategic partnership with ACUM, the local performing rights organization, Revelator will soon offer distribution to an additional 5,000 Israeli artists. The company is pursuing a U.S. launch and global expansion via a partnership with Africori, a digital music company representing over 300 record labels and thousands of artists in Africa. Revelator raised $500K in seed funding to continue expanding operations.

Led · Series B · Jun 2016

Liberty SBF provides short-term and permanent financing for owner-occupied commercial real estate and offers third-party servicing and capital markets services to its bank and credit union partners. The firm lends nationwide across a variety of asset types and specializes in SBA 504 loans for company owners as well as bridge loans and CMBS for property investors. Liberty SBF is led by CEO Alex Cohen and maintains offices in New York City, Philadelphia, Chicago and Los Angeles. The company raised new capital to expand its nationwide network and serve more small businesses seeking commercial property financing. In conjunction with its equity raise, Liberty SBF expanded credit facilities with Capital One Bank. The articles do not disclose revenue or other operating metrics.

Participated · Seed · Mar 2016

MedyMatch Technology develops AI-powered "deep vision and advanced cognitive analytics" for medical imaging to help radiologists and emergency physicians recognise hard-to-spot abnormalities. The company is currently applying its technology to stroke diagnosis to help distinguish hemorrhagic from ischemic strokes so clinicians can choose correct treatments. MedyMatch says its algorithms compare billions of data points in images to provide an augmented second opinion for emergency-room physicians and radiologists. To further develop and market the technology, the Tel Aviv and Boston-based startup raised a $2 million seed round from private and institutional investors, including Genesis Capital Advisors and Exigent Alternative Capital. Management recently appointed Gene Saragnese as chairman and CEO; he previously led Philips Imaging Systems and held senior roles at GE Healthcare. CFO and co-founder Michael Rosenberg notes doctors misdiagnose stroke patients roughly 30% of the time, underscoring the clinical need MedyMatch targets.